Skip to main content

MW 390.5 Da, Purity >99%. Selective VEGFR-2 inhibitor (IC50 = 700 nM). Shows antiangiogenic activity. Active in vivo.

Be the first to review this product! Submit a review

Images

Chemical Structure - SU 1498, VEGFR2 inhibitor (AB141447), expandable thumbnail

Publications

Key facts

CAS number
168835-82-3
Purity
> 99%
Form
Solid
Molecular weight
390.5 Da
Molecular formula
C25H30N2O2
PubChem identifier
5941539
Nature
Synthetic

Alternative names

Recommended products

MW 390.5 Da, Purity >99%. Selective VEGFR-2 inhibitor (IC50 = 700 nM). Shows antiangiogenic activity. Active in vivo.

Key facts

Purity
> 99%
PubChem identifier
5941539
Solubility

Soluble in ethanol to 100 mM.

Soluble in DMSO to 100 mM.

Biochemical name
(E)-2-Cyano-3-(4-hydroxy-3,5-diisopropylphenyl)-N-(3-phenylpropyl)acrylamide
Biological description

Selective VEGFR-2 inhibitor (IC50 = 700 nM). Shows antiangiogenic activity. Active in vivo.

Canonical SMILES
CC(C)C1=CC(=CC(=C1O)C(C)C)C=C(C#N)C(=O)NCCCC2=CC=CC=C2
Isomeric SMILES
CC(C)C1=CC(=CC(=C1O)C(C)C)/C=C(\C#N)/C(=O)NCCCC2=CC=CC=C2
InChI
InChI=1S/C25H30N2O2/c1-17(2)22-14-20(15-23(18(3)4)24(22)28)13-21(16-26)25(29)27-12-8-11-19-9-6-5-7-10-19/h5-7,9-10,13-15,17-18,28H,8,11-12H2,1-4H3,(H,27,29)/b21-13+
InChIKey
JANPYFTYAGTSIN-FYJGNVAPSA-N
IUPAC name
(E)-2-cyano-3-[4-hydroxy-3,5-di(propan-2-yl)phenyl]-N-(3-phenylpropyl)prop-2-enamide

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store in the dark, Store under desiccating conditions, This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes

Notes

It is important to note that this product has been reported to be unstable under a variety of conditions. In addition to being unstable to light and air after extended periods of time, this product is extremely unstable in polar solvents such as DMSO. Within 1 hour a DMSO solution showed signs of decomposition. We therefore recommend this material is only stored as the solid form at -20°C (or below), with the exclusion of light and air, and any solutions are made up fresh and used immediately

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

VEGF Receptor 2 also known as KDR or FLK-1 is a receptor tyrosine kinase with a mass of approximately 200 kDa. This receptor is mainly expressed on endothelial cells and is found in multiple body tissues where angiogenesis occurs such as the lungs and kidneys. VEGF Receptor 2 is responsible for binding to vascular endothelial growth factor (VEGF) which initiates a signaling cascade that promotes cell survival migration and new blood vessel formation.

Biological function summary

VEGF Receptor 2 plays an important role in angiogenesis and is essential for vascular development during both physiological and pathological processes. Through interactions with VEGF-A VEGF Receptor 2 forms a signaling complex that activates downstream pathways involved in cellular proliferation and differentiation. This receptor ensures a supply of nutrients and oxygen by facilitating the development of blood vessels in response to hypoxic conditions.

Pathways

The intracellular signaling initiated by VEGF Receptor 2 involves pathways like the PI3K/Akt pathway and the MAPK/ERK pathway. These pathways are critical for mediating cell survival growth and division. VEGF Receptor 2 is also closely related to VEGF Receptor 1 another member of the same receptor family which can modulate the receptor's activity by acting as a decoy receptor therefore affecting angiogenic responses.

Associated diseases and disorders

VEGF Receptor 2 has a significant role in cancer and age-related macular degeneration. In many tumors elevated VEGF levels lead to increased activity of VEGF Receptor 2 which results in abnormal blood vessel growth and tumor expansion. The receptor is also implicated in pathological angiogenesis associated with age-related macular degeneration as it promotes neovascularization that can lead to vision loss. Targeting VEGF Receptor 2 for therapeutic interventions often involves VEGF inhibitors which reduce its activity and slow disease progression.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Chemical Structure - SU 1498, VEGFR2 inhibitor (ab141447), expandable thumbnail

    Chemical Structure - SU 1498, VEGFR2 inhibitor (ab141447)

    2D chemical structure image of ab141447, SU 1498, VEGFR2 inhibitor

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com